Clinical Outcomes and Healthcare Resource Utilization for Gastrointestinal Acute Graft-versus-Host Disease after Allogeneic Transplantation for Hematologic Malignancy: A Retrospective US Administrative Claims Database Analysis-Reference-Cited by-同舟云学术

Clinical Outcomes and Healthcare Resource Utilization for Gastrointestinal Acute Graft-versus-Host Disease after Allogeneic Transplantation for Hematologic Malignancy: A Retrospective US Administrative Claims Database Analysis

Published:2019-04 Issue:4 Volume:25 Page:834-841
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Johnson Barbara H.,Taylor Aliki,Kim Gilwan,Drahos Jennifer^ORCID,Yang Jiao,Akbari Mona,Shah Nirav N.

Funder

Takeda Pharmaceutical Company

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference38 articles.

1. Uses and growth of hematopoietic cell transplantation;Horowitz,2004

2. Reduced mortality after allogeneic hematopoietic-cell transplantation;Gooley;New Engl J Med,2010

3. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time;Gratwohl;Bone Marrow Transplant,2005

4. Risk factors for acute GVHD and survival after hematopoietic cell transplantation;Jagasia;Blood,2012

5. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria;Flowers;Blood,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study;Hematology Reports;2024-05-06

2. Vedolizumab for second-line treatment of steroid-refractory gastrointestinal late acute graft-versus-host disease;Therapeutic Advances in Hematology;2024-01

3. Healthcare costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective;Blood Advances;2023-12-06

4. Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic review;Journal of the American Pharmacists Association;2023-07

5. Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France;Bone Marrow Transplantation;2023-02-10